Dexmedetomidine HCl in 0.9% NaCl; 4mcg/mL; soln for IV infusion. Precedex (dexmedetomidine hydrochloride) injection 200 mcg/2 mL (100 mcg/mL) is clear and colorless. The strength is based on the ...

Shares of Hospira (HSP) tumbled 2.81% to close the trading session on Aug 19 at $53.92 per share, following the company’s decision to file a lawsuit against the FDA over approvals granted to generic ...

LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that the U.S ...

Hospira has been in the news regarding Precedex for quite a while now. Last month, the FDA granted approval to companies like Mylan to launch their generic versions of the product. However, Hospira ...

Hospira's reprieve from generic Precedex competition was short-lived. The U.S. district court that temporarily stopped Precedex generics has now decided to let the copycats roll. And that could mean ...

The FDA has approved Precedex (dexmedetomidine HCl, from Hospira) injection for the sedation of non-intubated patients prior to and/or during surgical and other procedures. This approval is based on ...

Hospira challenged the U.S. regulator over patent protection earlier this week, claiming the FDA's decision to allow generics would violate its patent. Currently, Hospira has one remaining active IP ...

The US District Court for Maryland on August 19 granted Hospira a temporary restraining order (TRO) against FDA, the day after the agency determined that potential generic competitors of the company’s ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I being treated with PRECEDEX? PRECEDEX contains the active ...

A hospital in Tokyo that is affiliated to Nihon University incorrectly administered the sedative "Precedex" to patients in three different cases between 2015 and 2016, the Mainichi Shimbun has learned ...

LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE:HSP), a global specialty pharmaceutical and medication delivery company, announced today that ...